Abstract PD3-09: HER2 L755S Mutation is Acquired Upon Resistance to Lapatinib and Neratinib and Confers Cross-Resistance to Tucatinib and Trastuzumab in HER2-positive Breast Cancer Cell Models
Cancer Research（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined